vs
Side-by-side financial comparison of Ardent Health, Inc. (ARDT) and Cboe Global Markets (CBOE). Click either name above to swap in a different company.
Ardent Health, Inc. is the larger business by last-quarter revenue ($1.6B vs $1.3B, roughly 1.3× Cboe Global Markets). Cboe Global Markets runs the higher net margin — 30.3% vs 2.8%, a 27.5% gap on every dollar of revenue.
Goodlife Health Clubs is a chain of health clubs, with more than 80 locations in Australia.
Cboe Global Markets, Inc. is an American financial exchange operator headquartered in Chicago. It owns and operates a portfolio of exchanges and trading venues across equities, options, futures, and digital assets.
ARDT vs CBOE — Head-to-Head
Income Statement — Q4 FY2025 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $1.6B | $1.3B |
| Net Profit | $45.0M | $385.7M |
| Gross Margin | — | 57.3% |
| Operating Margin | 5.8% | 39.7% |
| Net Margin | 2.8% | 30.3% |
| Revenue YoY | — | 6.5% |
| Net Profit YoY | — | 53.9% |
| EPS (diluted) | $0.32 | $3.66 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | — | $1.3B | ||
| Q4 25 | $1.6B | $1.2B | ||
| Q3 25 | $1.6B | $1.1B | ||
| Q2 25 | $1.6B | $1.2B | ||
| Q1 25 | $1.5B | $1.2B | ||
| Q4 24 | — | $1.1B | ||
| Q3 24 | $1.4B | $1.1B | ||
| Q2 24 | $1.5B | $974.0M |
| Q1 26 | — | $385.7M | ||
| Q4 25 | $45.0M | $313.5M | ||
| Q3 25 | $-23.5M | $300.8M | ||
| Q2 25 | $73.0M | $235.1M | ||
| Q1 25 | $41.4M | $250.6M | ||
| Q4 24 | — | $196.5M | ||
| Q3 24 | $26.3M | $218.5M | ||
| Q2 24 | $42.8M | $140.4M |
| Q1 26 | — | 57.3% | ||
| Q4 25 | — | 55.7% | ||
| Q3 25 | — | 53.0% | ||
| Q2 25 | — | 50.0% | ||
| Q1 25 | — | 47.3% | ||
| Q4 24 | — | 47.4% | ||
| Q3 24 | — | 50.4% | ||
| Q2 24 | — | 52.8% |
| Q1 26 | — | 39.7% | ||
| Q4 25 | 5.8% | 33.5% | ||
| Q3 25 | -0.1% | 32.4% | ||
| Q2 25 | 7.4% | 28.9% | ||
| Q1 25 | 5.0% | 29.6% | ||
| Q4 24 | — | 27.0% | ||
| Q3 24 | 3.9% | 29.1% | ||
| Q2 24 | 5.6% | 21.6% |
| Q1 26 | — | 30.3% | ||
| Q4 25 | 2.8% | 26.0% | ||
| Q3 25 | -1.5% | 26.3% | ||
| Q2 25 | 4.4% | 20.0% | ||
| Q1 25 | 2.8% | 21.0% | ||
| Q4 24 | — | 17.7% | ||
| Q3 24 | 1.8% | 20.7% | ||
| Q2 24 | 2.9% | 14.4% |
| Q1 26 | — | $3.66 | ||
| Q4 25 | $0.32 | $2.97 | ||
| Q3 25 | $-0.17 | $2.85 | ||
| Q2 25 | $0.52 | $2.23 | ||
| Q1 25 | $0.29 | $2.37 | ||
| Q4 24 | — | $1.85 | ||
| Q3 24 | $0.19 | $2.07 | ||
| Q2 24 | $0.34 | $1.33 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $709.6M | $2.1B |
| Total DebtLower is stronger | $1.1B | $1.4B |
| Stockholders' EquityBook value | $1.3B | $5.4B |
| Total Assets | $5.3B | $11.1B |
| Debt / EquityLower = less leverage | 0.84× | 0.27× |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $2.1B | ||
| Q4 25 | $709.6M | $2.3B | ||
| Q3 25 | $609.4M | $1.5B | ||
| Q2 25 | $540.6M | $1.5B | ||
| Q1 25 | $495.0M | $1.2B | ||
| Q4 24 | — | $1.0B | ||
| Q3 24 | $563.1M | $763.2M | ||
| Q2 24 | $334.5M | $698.3M |
| Q1 26 | — | $1.4B | ||
| Q4 25 | $1.1B | $1.4B | ||
| Q3 25 | $1.1B | $1.4B | ||
| Q2 25 | $1.1B | $1.4B | ||
| Q1 25 | $1.1B | $1.4B | ||
| Q4 24 | — | $1.4B | ||
| Q3 24 | $1.1B | $1.4B | ||
| Q2 24 | $1.1B | $1.4B |
| Q1 26 | — | $5.4B | ||
| Q4 25 | $1.3B | $5.1B | ||
| Q3 25 | $1.2B | $4.9B | ||
| Q2 25 | $1.3B | $4.7B | ||
| Q1 25 | $1.2B | $4.5B | ||
| Q4 24 | — | $4.3B | ||
| Q3 24 | $1.0B | $4.2B | ||
| Q2 24 | $739.9M | $4.0B |
| Q1 26 | — | $11.1B | ||
| Q4 25 | $5.3B | $9.3B | ||
| Q3 25 | $5.2B | $9.1B | ||
| Q2 25 | $5.0B | $9.0B | ||
| Q1 25 | $4.9B | $8.7B | ||
| Q4 24 | — | $7.8B | ||
| Q3 24 | $4.8B | $8.7B | ||
| Q2 24 | $4.6B | $9.3B |
| Q1 26 | — | 0.27× | ||
| Q4 25 | 0.84× | 0.28× | ||
| Q3 25 | 0.88× | 0.30× | ||
| Q2 25 | 0.87× | 0.31× | ||
| Q1 25 | 0.93× | 0.32× | ||
| Q4 24 | — | 0.34× | ||
| Q3 24 | 1.08× | 0.34× | ||
| Q2 24 | 1.46× | 0.36× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $223.4M | — |
| Free Cash FlowOCF − Capex | — | — |
| FCF MarginFCF / Revenue | — | — |
| Capex IntensityCapex / Revenue | — | — |
| Cash ConversionOCF / Net Profit | 4.97× | — |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $223.4M | $352.1M | ||
| Q3 25 | $154.4M | $153.9M | ||
| Q2 25 | $117.5M | $333.7M | ||
| Q1 25 | $-24.8M | $912.9M | ||
| Q4 24 | — | $-710.4M | ||
| Q3 24 | $89.7M | $-578.5M | ||
| Q2 24 | — | $1.5B |
| Q1 26 | — | — | ||
| Q4 25 | — | $332.1M | ||
| Q3 25 | — | $137.9M | ||
| Q2 25 | — | $313.4M | ||
| Q1 25 | — | $898.2M | ||
| Q4 24 | — | $-734.2M | ||
| Q3 24 | — | $-590.5M | ||
| Q2 24 | — | $1.5B |
| Q1 26 | — | — | ||
| Q4 25 | — | 27.6% | ||
| Q3 25 | — | 12.1% | ||
| Q2 25 | — | 26.7% | ||
| Q1 25 | — | 75.2% | ||
| Q4 24 | — | -66.3% | ||
| Q3 24 | — | -55.9% | ||
| Q2 24 | — | 151.6% |
| Q1 26 | — | — | ||
| Q4 25 | — | 1.7% | ||
| Q3 25 | — | 1.4% | ||
| Q2 25 | — | 1.7% | ||
| Q1 25 | — | 1.2% | ||
| Q4 24 | — | 2.1% | ||
| Q3 24 | — | 1.1% | ||
| Q2 24 | — | 1.8% |
| Q1 26 | — | — | ||
| Q4 25 | 4.97× | 1.12× | ||
| Q3 25 | — | 0.51× | ||
| Q2 25 | 1.61× | 1.42× | ||
| Q1 25 | -0.60× | 3.64× | ||
| Q4 24 | — | -3.62× | ||
| Q3 24 | 3.41× | -2.65× | ||
| Q2 24 | — | 10.64× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ARDT
Segment breakdown not available.
CBOE
| Derivatives markets | $609.3M | 48% |
| Cash and spot markets | $482.2M | 38% |
| Data Vantage | $181.3M | 14% |
